Jonathan A Trujillo (Jonathan Trujillo)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Respiratory Syndrome Coronavirus

Ejection Fraction

Top Venues

Science advances

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Priscilla S Briquez, Sherin Juliet Rouhani, Jovian Yu, Athalia R Pyzer, Jonathan A Trujillo, Haley L Dugan, Christopher T Stamper, Siriruk Changrob, Anne I Sperling, Patrick C Wilson, Thomas F Gajewski, Jeffrey A Hubbell, Melody A Swartz
Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity. Science advances 8 (40) (2022)
Jonathan A Trujillo, James K Godfrey, Yifei Hu, Jun Huang, Sonali M Smith, Matthew J Frigault, Zachariah DeFilipp, Daniel Appelbaum, Yonglin Pu, Nicholas Feinberg, Thomas Althaus, Michael R Bishop, Peter A Riedell, Justin Kline
Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma. Blood 137 (24) (2021)
Jonathan A Trujillo, Jason J Luke, Yuanyuan Zha, Jeremy P Segal, Lauren L Ritterhouse, Stefani Spranger, Karen Matijevich, Thomas F Gajewski
Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma. Journal for immunotherapy of cancer 7 (1) (2019)